Hong Kong Stock Afternoon Review | Hang Seng Index rose 1.14% in early trading, Moderna cancer vaccine breakthrough ignites Hong Kong stock mRNA race

The Zhitong Finance App learned that the Hang Seng Index rose 1.14% to 291 points to 25,786 points in early trading; the Hang Seng Technology Index rose 1.54%; and Hong Kong stocks traded HK$144.1 billion in early trading.

The Hang Seng Innovative Drugs Index soared by more than 8%; the Hang Seng Biotech Index rose 6.94%.

The Moderna cancer vaccine breakthrough ignited the mRNA race, and Genting Xinyao (01952) surged 68%.

Cansino Biotech (06185) surged 51%. The mRNA tumor vaccine industry welcomed significant benefits, and the company already had a relevant layout.

Jietai Technology-P (07666) rose more than 32%. Moderna's major breakthrough opened up space for mRNA imagination, and the company has the ability to develop mRNA cancer vaccines.

Siludi Pharmaceuticals shares (01244) once soared 130% and rose more than 55% in midday trading. Tumor immunotherapy has reached a milestone, and the company's layout on the oncology circuit is aimed at the cutting edge of the international direction.

Kingsley Biotech (01548) rose more than 14%, AIDD demand was released at an accelerated pace, and institutions indicated that the performance exceeded expectations.

Jingfang Pharmaceutical-B (02595) rose by more than 12%, and GFH375, the world's first combination therapy for pancreatic cancer, entered phase II research.

Haizhi Technology Group (02706) rose more than 13%, and the Atlas dual product line drove growth, opening up platform space against Palantir.

Le Comfort (02698) rose more than 9% after the performance. Mid-term adjusted net profit increased 53.14% year on year, and the company continued to implement local production capacity.

Yixin Group (02858) rose more than 11%. Adjusted net profit increased 31% year-on-year to 850 million in the first half of the year, and the SaaS business became the core growth pole.

Zhaojin Mining (01818) rose more than 8%, the US Treasury expanded long-term bond repurchases to boost the precious metals market, and the Federal Reserve's high interest rate maintenance cycle loosened.

Times Electric (03898) fell more than 7%. Net profit in the first half of the year increased by only 2.44% year on year, and revenue from the new energy sector fell 60%.